Kozak & Associates, Inc. Lantheus Holdings, Inc. Transaction History
Kozak & Associates, Inc.
- $482 Million
- Q2 2025
A detailed history of Kozak & Associates, Inc. transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Kozak & Associates, Inc. holds 140 shares of LNTH stock, worth $10,108. This represents 0.0% of its overall portfolio holdings.
Number of Shares
140Holding current value
$10,108% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LNTH
# of Institutions
562Shares Held
77.2MCall Options Held
472KPut Options Held
186K-
Black Rock Inc. New York, NY8.6MShares$621 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$505 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X06.51MShares$470 Million0.36% of portfolio
-
Farallon Capital Management LLC San Francisco, CA6.02MShares$435 Million3.38% of portfolio
-
State Street Corp Boston, MA2.64MShares$190 Million0.01% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $4.96B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...